SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-000976
Filing Date
2022-06-21
Accepted
2022-06-21 08:31:17
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 e621762_8k-immunic.htm   iXBRL 8-K 23845
  Complete submission text file 0001193805-22-000976.txt   196752

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imux-20220615.xsd EX-101.SCH 2947
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20220615_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20220615_pre.xml EX-101.PRE 22351
6 EXTRACTED XBRL INSTANCE DOCUMENT e621762_8k-immunic_htm.xml XML 3695
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 221026193
SIC: 2834 Pharmaceutical Preparations